--- title: Advisory Team - Cheryl Allen description: Cheryl Allen, BS Pharm, MBA, brings over 25 years of industry experience to design patient-centric solutions in pharmaceutical access and support services. --- [Skip to content](https://www.curatioadvisors.com/advisory-team-cheryl-allen#main-content) [![Curatio Logo-2](https://www.curatioadvisors.com/hubfs/Curatio%20Logo-2.png)](https://www.curatioadvisors.com?hsLang=en) ![Toggle Open Icon-1](https://www.curatioadvisors.com/hubfs/Toggle%20Open%20Icon-1.png) ![menu-close](https://21645388.fs1.hubspotusercontent-na1.net/hubfs/21645388/menu-close.svg) - [Home](https://www.curatioadvisors.com) - [Services](https://www.curatioadvisors.com/services) Show submenu for Services - [Pharma Manufacturers](https://www.curatioadvisors.com/services#A-PharmaManuf) - [Specialty & Infusion Pharmacies](https://www.curatioadvisors.com/services#B-SpecialtyInfusion) - [Private Equity](https://www.curatioadvisors.com/services#C-PrivateEquity) - [Pharma Services Providers](https://www.curatioadvisors.com/services#D-PharmaServices) - [Rapid Response](https://www.curatioadvisors.com/rapid-response) - [Advisory Team](https://www.curatioadvisors.com/advisory-team) Show submenu for Advisory Team - [About](https://www.curatioadvisors.com/about-us) - [Become a Curatio Advisor](https://www.curatioadvisors.com/become-a-curatio-advisor) - [Industry Insights](https://www.curatioadvisors.com/industry-insights) Show submenu for Industry Insights - [Reports & Research](https://www.curatioadvisors.com/reports) - [Advisory Briefs](https://www.curatioadvisors.com/insights/advisory-briefs) - [Market Intelligence](https://www.curatioadvisors.com/market-intelligence) - [Events](https://www.curatioadvisors.com/events) - [Contact Us](https://www.curatioadvisors.com/contact-us) - [Home](https://www.curatioadvisors.com) - [Services](https://www.curatioadvisors.com/services) Show submenu for Services - [Pharma Manufacturers](https://www.curatioadvisors.com/services#A-PharmaManuf) - [Specialty & Infusion Pharmacies](https://www.curatioadvisors.com/services#B-SpecialtyInfusion) - [Private Equity](https://www.curatioadvisors.com/services#C-PrivateEquity) - [Pharma Services Providers](https://www.curatioadvisors.com/services#D-PharmaServices) - [Rapid Response](https://www.curatioadvisors.com/rapid-response) - [Advisory Team](https://www.curatioadvisors.com/advisory-team) Show submenu for Advisory Team - [About](https://www.curatioadvisors.com/about-us) - [Become a Curatio Advisor](https://www.curatioadvisors.com/become-a-curatio-advisor) - [Industry Insights](https://www.curatioadvisors.com/industry-insights) Show submenu for Industry Insights - [Reports & Research](https://www.curatioadvisors.com/reports) - [Advisory Briefs](https://www.curatioadvisors.com/insights/advisory-briefs) - [Market Intelligence](https://www.curatioadvisors.com/market-intelligence) - [Events](https://www.curatioadvisors.com/events) - [Contact Us](https://www.curatioadvisors.com/contact-us) This is a search field with an auto-suggest feature attached. - There are no suggestions because the search field is empty. ![Toggle Open Icon-1](https://www.curatioadvisors.com/hubfs/Toggle%20Open%20Icon-1.png) ![menu-close](https://21645388.fs1.hubspotusercontent-na1.net/hubfs/21645388/menu-close.svg) ## TEAM # Experience [know more](https://www.hubspot.com/) - [Home](https://www.hubspot.com/)\> - Author ![Cheryl\_Bio Headshot-1](https://www.curatioadvisors.com/hubfs/Cheryl_Bio%20Headshot-1.png) ## PARTNER ## Cheryl Allen ###### BS Pharm, MBA   Cheryl works with pharmaceutical manufacturers and other stakeholders in the channel leveraging her two plus decades of Industry experience to design business strategies to effectively deliver value in patient access and support services. Cheryl has a unique ability to truly empathize with all constituents to create the optimal patient and prescriber journey. She understands the benefits and hurdles and is skilled at using process, data, and technology to create patient centric solutions. Cheryl brings more than 25 years of industry experience, with work in independent and specialty pharmacy, as well as in managed care consulting and health care IT. Prior to Curatio, Cheryl served as Chief Growth Officer at PANTHERx, Executive Vice President, Business Development at Specialty Pharmacy Nursing Network and EVP of Business Development and Industry Relations at Asembia. Before Asembia, Cheryl was Principal Consultant at Blue Fin Group and Cheryl served as Vice President of Business Development and Industry Relations at Diplomat. Prior to Diplomat, Cheryl was Senior Director of Clinical Services at Sanovia Corporation, where she managed new product development and sales support. Cheryl also held roles with Priority HealthCare as a pharmacist-in-charge for oncology and lead pharmacist for pain management. Cheryl founded C. Allen & Associates, a firm focused on managed care consulting, and Eden Drug Company, an independent specialty pharmacy. Cheryl earned her Bachelor of Science in pharmacy at Samford University’s McWhorter School of Pharmacy, in Birmingham, Alabama and her MBA at Saint Joseph’s University Erivan K. Haub School of Business with a focus in pharmaceutical and health care marketing in Philadelphia, Pennsylvania. ## Blogs   [![https://46970799.fs1.hubspotusercontent-na1.net/hubfs/46970799/AI-Generated%20Media/Images/technologyenabled%20solutions%20such%20as%20patient%20messaging%2c%20ai%2c%20automations%20to%20improve%20patient%20satisfaction%2c%20treatment%20adherence%2c%20and%20healthcare%20efficiency.jpeg](https://www.curatioadvisors.com/hubfs/AI-Generated%20Media/Images/technologyenabled%20solutions%20such%20as%20patient%20messaging%2c%20ai%2c%20automations%20to%20improve%20patient%20satisfaction%2c%20treatment%20adherence%2c%20and%20healthcare%20efficiency.jpeg)](https://www.curatioadvisors.com/industry-insights/enhancing-patient-access-and-support-through-technology-a-comprehensive-assessment?hsLang=en) ##### [ARTICLE: Enhancing Patient Access and Support Through Technology](https://www.curatioadvisors.com/industry-insights/enhancing-patient-access-and-support-through-technology-a-comprehensive-assessment?hsLang=en) By [Curatio Advisors](https://www.curatioadvisors.com/industry-insights/author/curatio-advisors?hsLang=en) 21 September 2024 August 9, 2024, in Pharmaceutical Commerce publication, Cheryl Allen, BS Pharm, MBA, and Jon... [read more](https://www.curatioadvisors.com/industry-insights/enhancing-patient-access-and-support-through-technology-a-comprehensive-assessment?hsLang=en) [![https://46970799.fs1.hubspotusercontent-na1.net/hubfs/46970799/AI-Generated%20Media/Images/new%20FDA%20approval%20implications%20on%20Alzheimers%20drugs.jpeg](https://www.curatioadvisors.com/hubfs/AI-Generated%20Media/Images/new%20FDA%20approval%20implications%20on%20Alzheimers%20drugs.jpeg)](https://www.curatioadvisors.com/industry-insights/fda-approval-implications-for-patient-access-to-therapy?hsLang=en) ##### [BLOG: FDA Approval Implications for Patient Access to Therapy](https://www.curatioadvisors.com/industry-insights/fda-approval-implications-for-patient-access-to-therapy?hsLang=en) By [Curatio Advisors](https://www.curatioadvisors.com/industry-insights/author/curatio-advisors?hsLang=en) 21 September 2024 The pace of innovation in the pharmaceutical pipeline is incredible with novel... [read more](https://www.curatioadvisors.com/industry-insights/fda-approval-implications-for-patient-access-to-therapy?hsLang=en) [![https://46970799.fs1.hubspotusercontent-na1.net/hubfs/46970799/Wesbite%20Header\_Logo%20and%20Name%20White%20Background.png](https://www.curatioadvisors.com/hubfs/Wesbite%20Header_Logo%20and%20Name%20White%20Background.png)](https://www.curatioadvisors.com/industry-insights/wishing-you-a-strong-start-to-2026?hsLang=en) ##### [Wishing You a Strong Start to 2026](https://www.curatioadvisors.com/industry-insights/wishing-you-a-strong-start-to-2026?hsLang=en) By [Curatio Advisors](https://www.curatioadvisors.com/industry-insights/author/curatio-advisors?hsLang=en) 3 February 2026 {% module\_block module "widget\_144eac0e-364c-4827-b352-8069a096e4fc" %}{% module\_attribute... [read more](https://www.curatioadvisors.com/industry-insights/wishing-you-a-strong-start-to-2026?hsLang=en) ## CONNECT WITH US ## Grow Your Bussiess with us Sed amet dolor penatibus sed at posuere justo, lacinia neque.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Leo nec felis at pellentesque. Sed amet dolor penatibus sed at posuere justo, lacinia neque.Lorem ipsum dolor sit amet, consectetur adipiscing elit. [view more](https://www.hubspot.com/) [have query](https://www.hubspot.com/) [![Curatio Advisors Horizontal with White Stroke 2](https://www.curatioadvisors.com/hubfs/Curatio%20Advisors%20Horizontal%20with%20White%20Stroke%202.png)](https://www.curatioadvisors.com/contact-us?hsLang=en) Curatio Advisors is your trusted independent advisory support partners that provides innovative solutions that support access and positive outcomes in the patient journey with complex drug therapies. - [Home](https://www.curatioadvisors.com) - [Services](https://www.curatioadvisors.com/services) - [Advisory Team](https://www.curatioadvisors.com/advisory-team) - [Industry Insights](https://www.curatioadvisors.com/industry-insights) - [Events](https://www.curatioadvisors.com/events) - [Contact Us](https://www.curatioadvisors.com/contact-us) ###### Get In Touch info@curatioadvisors.com - Copyright © 2026 Curatio Scientia Advisors, All Rights Reserved. [Code of Conduct |](https://www.curatioadvisors.com/code-of-conduct?hsLang=en) [Sustainability Policy](https://www.curatioadvisors.com/sustainability-policy?hsLang=en)